Edition:
United States

People: Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

12.27USD
23 Oct 2018
Change (% chg)

$0.20 (+1.66%)
Prev Close
$12.07
Open
$11.84
Day's High
$13.26
Day's Low
$11.45
Volume
567,719
Avg. Vol
376,230
52-wk High
$25.92
52-wk Low
$11.45

Fishman, Robert 

Dr. Robert S. Fishman is Chief Medical Officer of Corcept Therapeutics Incorporated. From May 2012 to March 2015, Dr. Fishman served as the Senior Vice President of Clinical Development at InterMune, Inc., a biopharmaceutical company. Prior to his tenure at InterMune, Dr. Fishman served as Vice President of Clinical Development at Alexza Pharmaceuticals, a biopharmaceutical company, from September 2007 to May 2012. Before that, he held positions of increasing responsibility at Heatport, Aerogen and Anthera Pharmaceuticals. Dr. Fishman trained in internal medicine at Deaconess Hospital, Boston, completed a fellowship in pulmonary and critical care medicine at Massachusetts General Hospital and began his career as a member of the Stanford pulmonary medicine faculty. He earned an A.B. in Biology from Harvard and an M.D. from Stanford University School of Medicine.

Basic Compensation

Total Annual Compensation, USD 598,779
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 531,294
Fiscal Year Total, USD 1,130,070

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Wilson

818,575

Joseph Belanoff

4,271,450

Gary Robb

1,780,520

Sean Maduck

2,754,740

Robert Fishman

1,130,070

G. Leonard Baker

287,691
As Of  30 Dec 2017